234 related articles for article (PubMed ID: 32259534)
1. Dysregulation of trophic factors contributes to diabetic retinopathy in the Ins2
Araújo RS; Silva MS; Santos DF; Silva GA
Exp Eye Res; 2020 May; 194():108027. PubMed ID: 32259534
[TBL] [Abstract][Full Text] [Related]
2. Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2
Wang W; Tam KC; Ng TC; Goit RK; Chan KLS; Lo ACY
BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32665315
[TBL] [Abstract][Full Text] [Related]
3. Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina.
McLenachan S; Chen X; McMenamin PG; Rakoczy EP
Clin Exp Ophthalmol; 2013 Aug; 41(6):582-92. PubMed ID: 23433122
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
5. Angiography reveals novel features of the retinal vasculature in healthy and diabetic mice.
McLenachan S; Magno AL; Ramos D; Catita J; McMenamin PG; Chen FK; Rakoczy EP; Ruberte J
Exp Eye Res; 2015 Sep; 138():6-21. PubMed ID: 26122048
[TBL] [Abstract][Full Text] [Related]
6. Polyphenol Metabolite Pyrogallol-
Santos DF; Pais M; Santos CN; Silva GA
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768833
[TBL] [Abstract][Full Text] [Related]
7. Retinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathy.
Han Z; Guo J; Conley SM; Naash MI
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):574-84. PubMed ID: 23221078
[TBL] [Abstract][Full Text] [Related]
8. The Ins2Akita mouse as a model of early retinal complications in diabetes.
Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643
[TBL] [Abstract][Full Text] [Related]
9. Sustained intraocular vascular endothelial growth factor neutralisation does not affect retinal and choroidal vasculature in Ins2
Lechner J; Hombrebueno JR; Pedrini E; Chen M; Xu H
Diab Vasc Dis Res; 2019 Sep; 16(5):440-449. PubMed ID: 31023085
[TBL] [Abstract][Full Text] [Related]
10. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT
Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465
[TBL] [Abstract][Full Text] [Related]
11. Influence of endotoxin-mediated retinal inflammation on phenotype of diabetic retinopathy in Ins2 Akita mice.
Vagaja NN; Binz N; McLenachan S; Rakoczy EP; McMenamin PG
Br J Ophthalmol; 2013 Oct; 97(10):1343-50. PubMed ID: 23913246
[TBL] [Abstract][Full Text] [Related]
12. Antagonising Wnt/β-catenin signalling ameliorates lens-capsulotomy-induced retinal degeneration in a mouse model of diabetes.
Hombrebueno JR; Ali IHA; Ma JX; Chen M; Xu H
Diabetologia; 2018 Nov; 61(11):2433-2446. PubMed ID: 30019207
[TBL] [Abstract][Full Text] [Related]
13. Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice.
Liu Y; Leo LF; McGregor C; Grivitishvili A; Barnstable CJ; Tombran-Tink J
Mol Med; 2012 Dec; 18(1):1387-401. PubMed ID: 23019073
[TBL] [Abstract][Full Text] [Related]
14. Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2
Elshaer SL; Evans W; Pentecost M; Lenin R; Periasamy R; Jha KA; Alli S; Gentry J; Thomas SM; Sohl N; Gangaraju R
Stem Cell Res Ther; 2018 Nov; 9(1):322. PubMed ID: 30463601
[TBL] [Abstract][Full Text] [Related]
15. Novel transgenic mouse models develop retinal changes associated with early diabetic retinopathy similar to those observed in rats with diabetes mellitus.
Guo C; Zhang Z; Zhang P; Makita J; Kawada H; Blessing K; Kador PF
Exp Eye Res; 2014 Feb; 119():77-87. PubMed ID: 24370601
[TBL] [Abstract][Full Text] [Related]
16. Loss-of-function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice.
Jiang H; Du J; Song J; Li Y; Wu M; Zhou J; Wu S
Exp Eye Res; 2018 Oct; 175():90-97. PubMed ID: 29913163
[TBL] [Abstract][Full Text] [Related]
17. Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes.
Muir ER; Rentería RC; Duong TQ
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6488-94. PubMed ID: 22915034
[TBL] [Abstract][Full Text] [Related]
18. The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy.
Chaurasia SS; Lim RR; Parikh BH; Wey YS; Tun BB; Wong TY; Luu CD; Agrawal R; Ghosh A; Mortellaro A; Rackoczy E; Mohan RR; Barathi VA
Sci Rep; 2018 Feb; 8(1):2847. PubMed ID: 29434227
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
